Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 8:2019:7831952.
doi: 10.1155/2019/7831952. eCollection 2019.

Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

Affiliations
Review

Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

B Poljsak et al. Oxid Med Cell Longev. .

Abstract

A clear understanding of the origins of cancer is the basis of successful strategies for effective cancer prevention and management. The origin of cancer at the molecular and cellular levels is not well understood. Is the primary cause of the origin of cancer the genomic instability or impaired energy metabolism? An attempt was made to present cancer etiology originating from life's major evolutionary transition. The first evolutionary transition went from simple to complex cells when eukaryotic cells with glycolytic energy production merged with the oxidative mitochondrion (The Endosymbiosis Theory first proposed by Lynn Margulis in the 1960s). The second transition went from single-celled to multicellular organisms once the cells obtained mitochondria, which enabled them to obtain a higher amount of energy. Evidence will be presented that these two transitions, as well as the decline of NAD+ and ATP levels, are the root of cancer diseases. Restoring redox homeostasis and reactivation of mitochondrial oxidative metabolism are important factors in cancer prevention.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1
Figure 1
O2 and NAD+ as limiting factors in driving oxidative phosphorylation. The figure presents a hypothesis that in situations with limited availability of NAD+, the cells will activate the program which switches off Krebs cycle and electron transport chain (process consumes 6 NAD+) and favors glycolysis (process consumes 2 NAD+) in order to obtain energy, preserve NAD+, and avoid cell death through reduced ATP production and activation of apoptosis. Abbreviations: PARP: poly(adenosine diphosphate [ADP] ribose) polymerases; CD38: NAD+ glycohydrolases; sirtuins: NAD-dependent histone deacetylase (“HDAC”) enzymes.
Figure 2
Figure 2
Metabolic alterations produce genetic alterations (activation of oncogenes and repression of tumor suppressor genes) which influence cancer development. What the causes are of metabolic alteration is still a matter of debate. Potential candidates involved in the metabolic switch from respiration to fermentation are increased inflammation, increased ROS formation, overstimulation of PARPs, decreased intracellular energy levels, and damaged respiration.

References

    1. Baker S. G. A cancer theory kerfuffle can lead to new lines of research. Journal of the National Cancer Institute. 2014;107(2):p. dju405. doi: 10.1093/jnci/dju405. - DOI - PMC - PubMed
    1. Martincorena I., Roshan A., Gerstung M., et al. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348(6237):880–886. doi: 10.1126/science.aaa6806. - DOI - PMC - PubMed
    1. Martincorena I., Fowler J. C., Wabik A., et al. Somatic mutant clones colonize the human esophagus with age. Science. 2018;362(6417):911–917. doi: 10.1126/science.aau3879. - DOI - PMC - PubMed
    1. Seyfried T. N. Cancer as a mitochondrial metabolic disease. Frontiers in Cell and Development Biology. 2015;3 doi: 10.3389/fcell.2015.00043. - DOI - PMC - PubMed
    1. Kaipparettu B. A., Ma Y., Park J. H., et al. Crosstalk from non-cancerous mitochondria can inhibit tumor properties of metastatic cells by suppressing oncogenic pathways. PLoS One. 2013;8(5):p. e61747. doi: 10.1371/journal.pone.0061747. - DOI - PMC - PubMed

LinkOut - more resources